Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kannan Muthuramalingam"'
Autor:
Bella Devaleenal Daniel, Elilarasi Selladurai, Sarath Balaji, Arunagirinathan Venkatesan, Mythily Venkatesan, Prathiksha Giridharan, Sivakumar Shanmugam, Saravanan Natrajan, Ramesh Karunaianantham, Devika Kandasamy, Rajakumar Subramani, Kannan Muthuramalingam, Snegha K. Pramila, Syed Hissar, Kelly E. Dooley, Kiran T. Thakur
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 11 (2024)
Background: Children with tuberculous meningitis (TBM) present with diagnostic challenges as they often have atypical clinical features. Objective: To describe the baseline characteristic features of children diagnosed with central nervous system (CN
Externí odkaz:
https://doaj.org/article/a63ec45be3f4415b9bff2ff33acc52bb
Autor:
Narayanaiah Cheedarla, Babu Hemalatha, Brahmaiah Anangi, Kannan Muthuramalingam, Murugesan Selvachithiram, Pattabiraman Sathyamurthi, Nandagopal Kailasam, Raghavan Varadarajan, Soumya Swaminathan, Srikanth Prasad Tripathy, S. Kalyanaraman Vaniambadi, D. Ramanathan Vadakkupattu, Luke Elizabeth Hanna
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Strain-specific neutralizing antibodies develop in all human immunodeficiency virus type 1 (HIV-1)-infected individuals. However, only 10–30% of infected individuals produce broadly neutralizing antibodies (bNAbs). Identification and characterizati
Externí odkaz:
https://doaj.org/article/02ec40529aa24a7f93eebeab3b09316b
Autor:
Aishwarya Venkataraman, Sivakumar Shanmugam, Sarath Balaji, Karthick Mani, Ashok Kumar Shanmugavel, Kannan Muthuramalingam, Syed Hissar, Kannan Thiruvengadam, Elilarasi Selladurai, Melanie Smuk, Luke Elizabeth Hanna, Andrew J. Prendergast
Publikováno v:
Tuberculosis. 137:102255
A major challenge in tuberculosis is identifying correlates of a protective immune response. The Mycobacterial Growth Inhibition Assay (MGIA) is a functional assay providing an integrated measure of the host immune response to mycobacteria. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc46e6073d97a136796a75924b866b39
https://doi.org/10.1016/j.tube.2022.102255
https://doi.org/10.1016/j.tube.2022.102255
Autor:
Srikanth Tripathy, Lucia Precilla Karunakaran, Sathyamurthi Pattabiraman, Luke Elizabeth Hanna, Kannan Muthuramalingam, Manohar Nesakumar, Evangeline Ann Daniel, Bennett Henzeler Esakialraj L, Selvaraj Anbalagan, Ramesh Karunaianantham, Murugesan Selvachithiram, Sudhakar Natarajan
Publikováno v:
Diagnostic Microbiology and Infectious Disease
SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1270e2a05405284661358b78aabe2a46
https://doi.org/10.1016/j.diagmicrobio.2021.115432
https://doi.org/10.1016/j.diagmicrobio.2021.115432
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D. Ramanathan Vadakkupattu, Soumya Swaminathan, Murugesan Selvachithiram, Babu Hemalatha, Nandagopal Kailasam, Brahmaiah Anangi, Luke Elizabeth Hanna, S. Kalyanaraman Vaniambadi, Pattabiraman Sathyamurthi, Raghavan Varadarajan, Srikanth Tripathy, Narayanaiah Cheedarla, Kannan Muthuramalingam
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology, Vol 9 (2018)
Strain-specific neutralizing antibodies develop in all human immunodeficiency virus type 1 (HIV-1)-infected individuals. However, only 10–30% of infected individuals produce broadly neutralizing antibodies (bNAbs). Identification and characterizati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5091e18b05bc856f4f519474fd227eee
http://europepmc.org/articles/PMC5890096
http://europepmc.org/articles/PMC5890096
Autor:
Kumar SR; Scientist F (Medical) , ICMR-National Institute for Research in Tuberculosis, Madurai Unit, Madurai, Tamil Nadu, India., Kandhasamy C; Principal Technical Officer, ICMR-National Institute for Research in Tuberculosis, Madurai Unit, Madurai, Tamil Nadu, India., Velayutham VB; Scientist E (Medical) , ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India., Chinnaiyan P; Scientist E, ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India., Kannan M; Technical Officer A, ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India., Jawahar MS; Former Scientist G (Medical), ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India., Padmapriyadarsini C; Scientist G and Director, ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Publikováno v:
Indian journal of public health [Indian J Public Health] 2024 Jul 01; Vol. 68 (3), pp. 362-365. Date of Electronic Publication: 2024 Sep 24.